DNTH
$72.09-3.27%
Dianthus Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.010%US Stock Market 0.007%Russell 3000 0.006%
DNTH financial statements
The full income statement, balance sheet, and cash-flow statement for Dianthus Therapeutics Inc. (DNTH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 29.4M2024-09 29.6M2024-12 32.1M2025-03 32.2M2025-06 32.2M2025-09 42.9M2025-12 44.5M2026-03 54.7M2026-06 55.9M+90.5% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 2.04M-67.3% | 6.24M+120.6% | 2.83M | — | — | |
| 180M+66.5% | 108M+112.0% | 51.0M+41.2% | 36.1M-51.6% | 74.7M-5.1% | ||
| Research & development | 146M+75.2% | 83.1M+153.1% | 32.8M+11.8% | 29.4M-37.2% | 46.8M-7.6% | |
| Selling, general & administrative | 34.3M+37.4% | 25.0M+37.6% | 18.2M+169.3% | 6.74M-75.9% | 27.9M-0.6% | |
| General & administrative | 34.3M+37.4% | 25.0M+37.6% | 18.2M+169.3% | 6.74M-75.9% | 27.9M-0.6% | |
| Operating income | -178M-74.7% | -102M-111.5% | -48.2M-62.2% | -29.7M+60.2% | -74.7M+5.1% | |
| Interest & investment income | 9.96M-12.3% | 11.3M+239.6% | 3.34M | — | — | |
| Other non-operating income | -974K-75.8% | -554K-823.3% | -60.0K-15.4% | -52.0K | — | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net income | -162M-91.1% | -85.0M-95.1% | -43.6M-53.0% | -28.5M+60.0% | -71.1M+5.1% | |
| -$4.20-64.7% | -$2.55+69.8% | -$8.45+74.1% | -$32.57-2424.8% | -$1.29+24.6% | ||
| EPS (basic) | -$4.20-64.7% | -$2.55+69.8% | -$8.45+74.1% | -$32.57-2424.8% | -$1.29+24.6% | |
| Weighted-avg shares (basic) | 38.6M+15.9% | 33.3M+546.4% | 5.15M+489.5% | 874K-98.4% | 54.9M+25.1% | |
| Weighted-avg shares (diluted) | 38.6M+15.9% | 33.3M+546.4% | 5.15M+489.5% | 874K-98.4% | 54.9M+25.1% | |
| Dividends per share | $0.00 | $0.00 | $0.00 | — | — | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 409M+45.8% | 281M+58.3% | 177M+116.3% | 82.0M-54.6% | 181M+19.2% | ||
| Cash & equivalents | 51.1M+124.1% | 22.8M-82.8% | 132M+761.2% | 15.4M-88.3% | 132M+126.4% | |
| Short-term investments | 353M+39.9% | 252M+509.9% | 41.4M-31.2% | 60.1M+32.8% | 45.3M-50.1% | |
| Cash & short-term investments | 50.2M+129.0% | 21.9M-83.3% | 131M | — | — | |
| Accounts receivable | 52.0K | 0.00-100.0% | 294K-93.7% | 4.70M | — | |
| Prepaid expenses | 5.09M+4.8% | 4.86M+49.2% | 3.25M+259.7% | 905K-76.0% | 3.77M+39.9% | |
| Other current assets | 86.0K-75.8% | 355K | 0.00 | — | — | |
| 531M+42.0% | 374M+108.5% | 179M+115.9% | 83.1M-56.2% | 190M+17.5% | ||
| Property, plant & equipment | 296K+52.6% | 194K+4.9% | 185K+30.3% | 142K-98.1% | 7.46M-10.2% | |
| Operating lease right-of-use | 1.34M-13.9% | 1.55M+152.5% | 615K-24.4% | 814K | 0.00 | |
| Long-term investments | 110M+34.8% | 81.7M | 0.00 | — | — | |
| 30.7M+66.6% | 18.5M+91.6% | 9.63M+17.1% | 8.22M-24.3% | 10.9M-5.0% | ||
| Accounts payable | 9.72M+112.4% | 4.58M+75.4% | 2.61M+123.7% | 1.17M-61.6% | 3.04M-19.1% | |
| Accrued liabilities | 19.5M+48.8% | 13.1M+101.0% | 6.50M-1.6% | 6.61M-15.5% | 7.82M+2.0% | |
| Deferred revenue | 1.19M+148.0% | 479K | 0.00-100.0% | 100K | — | |
| Current lease liability | 367K+14.7% | 320K-23.3% | 417K+19.1% | 350K | 0.00 | |
| 37.5M+74.3% | 21.5M+104.4% | 10.5M+11.4% | 9.45M-45.2% | 17.3M-2.5% | ||
| Deferred revenue (non-current) | 5.77M+202.4% | 1.91M | 0.00-100.0% | 791K | — | |
| Non-current lease liability | 1.02M-13.0% | 1.17M+597.0% | 168K-61.6% | 438K | 0.00 | |
| Operating lease liability (total) | 1.39M-7.0% | 1.49M+154.9% | 585K-98.0% | 30.0M | — | |
| Finance lease liability (total) | 0.00 | 0.00 | 0.00 | — | — | |
| 493M+40.0% | 352M+108.7% | 169M+480.6% | -44.4M-157.2% | -17.2M-112.0% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 43.0K+38.7% | 31.0K+106.7% | 15.0K | 0.00-100.0% | 59.0K+20.4% | |
| Additional paid-in capital | 830M+57.5% | 527M+104.0% | 258M+15446.7% | 1.66M-99.7% | 498M+25.1% | |
| Retained earnings | -337M-93.1% | -174M-95.0% | -89.4M-95.0% | -45.9M+85.9% | -326M-28.0% | |
| Accumulated other comprehensive income | 489K+361.3% | 106K+125.5% | 47.0K+129.2% | -161K-436.7% | -30.0K-30.4% | |
| Total liabilities & equity | 531M+42.0% | 374M+108.5% | 179M+115.9% | 83.1M-56.2% | 190M+17.5% | |
| Common shares issued | 43.2M+38.9% | 31.1M+110.0% | 14.8M+1592.9% | 875K-98.5% | 58.8M+21.1% | |
| Common shares outstanding | 43.2M+38.9% | 31.1M+110.0% | 14.8M+1592.9% | 875K-98.5% | 58.8M+21.2% | |
| Shares outstanding (cover) | 44.5M+38.4% | 32.1M+9.5% | 29.3M-51.6% | 60.6M+3.1% | 58.8M+21.1% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -129M-65.1% | -78.2M-112.1% | -36.9M-26.8% | -29.1M+51.2% | -59.5M+7.0% | ||
| Depreciation & amortization | 111K+15.6% | 96.0K+43.3% | 67.0K-96.5% | 1.93M-4.7% | 2.02M+2.1% | |
| Share-based compensation | 22.8M+76.8% | 12.9M+344.6% | 2.90M+91.0% | 1.52M-85.3% | 10.3M+3.7% | |
| Change in receivables | 52.0K | 0.00 | — | — | — | |
| Change in payables | — | — | — | -801K-11.3% | -720K-175.9% | |
| -123M+57.2% | -287M-1516.1% | 20.3M+133.9% | -59.8M-237.7% | 43.4M+508.3% | ||
| Capital expenditure | 213K+102.9% | 105K-4.5% | 110K-65.0% | 314K-75.2% | 1.26M+216.0% | |
| Free cash flow | -129M-65.1% | -78.3M-111.7% | -37.0M-25.8% | -29.4M+51.7% | -60.8M+5.6% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Purchases of investments | 435M+5.2% | 414M+620.5% | 57.4M | — | — | |
| 280M+9.6% | 256M+91.4% | 134M+38.2% | 96.7M+7.9% | 89.6M+32.3% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 317K | 0.00 | 0.00-100.0% | 2.90M | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 28.2M+125.8% | -109M-193.5% | 117M+1402.1% | 7.79M-89.4% | 73.5M+1162.3% | |
| Interest paid | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Income taxes paid | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.83B+161.7% | 700M+354.4% | 154M-60.2% | 388M-90.7% | 4.17B-31.6% | |
| P/S | 900.1×+701.4% | 112.3× | — | — | — | |
| P/B | 3.7×+86.9% | 2.0×+130.0% | 0.9× | — | — | |
| Dividend yield | 0.00% | 0.00% | 0.00% | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: DNTH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all DNTH filings on SEC EDGAR → Not investment advice.